Company Overview and News
ATLANTA—Georgia Democrats, long underdogs in this red state, hoped to present a unified front this year as they pushed to elect a governor, a post they haven’t held since 2003.
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Southwest Airlines Co (NYSE:LUV) has really struggled this year, with LUV stock down almost 20%. Ouch. That’s a pretty poor performance for a company that’s actually doing well. Given the huge decline so far this year, many investors are starting to wonder whether Southwest Airlines stock is a name to add to their portfolio.
NEW YORK – AeroVironment Inc. was accused of trying to conceal that employees transported a drone rigged with explosives on a commercial flight and retaliating against a manager who told the government.
NEW YORK: United Airlines' chief financial officer, Andrew Levy, has stepped down, the carrier said on Thursday, a major management shakeup at a time when the airline's financial performance has been lagging rivals.
United Continental CFO Andrew Levy left the company. Levy leave behind one of the weakest large public corporation CEOs in America–Oscar Munoz. Munoz has presided over a number of public relations disasters which undermined its brands and probably cost his the chairman’s position. The performance of United has been poor against its peer group. Levy had been CFO for nearly two years. From appearances, it looks like Levy in place of Munoz
The trigger for an unprecedented lobbying campaign was likely this: Emirates launched daily flights from Milan to New York on Oct. 1, 2013. The flights were in line with the open skies agreement between the U.S. and the United Arab Emirates, but they were a shock to American Airlines, Delta Air Lines and United Airlines, which wondered: What if Emirates launches more routes like this? What if Qatar Airways and Etihad do the same? And what if there is actually strong competition on the North .
NEW YORK (Reuters) - United Airlines’ (UAL.N) chief financial officer, Andrew Levy, is stepping down, the carrier said on Thursday, in a major management shuffle amid the airline’s lagging financial performance versus rivals.
The stock isn't the best bargain in the airline sector despite the stock weakness and the additional risks.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Remington Outdoor Co Inc , one of the largest U.S. makers of firearms, emerged from Chapter 11 bankruptcy on Thursday after completing a debt-cutting deal with creditors.
(Reuters) - U.S. weapons manufacturer Remington Outdoor Co Inc FREDM.UL said on Thursday it had emerged from Chapter 11 bankruptcy with less debt and more stable financing that may help it ride out a slowing market for firearms.
JACKSON, Miss. (AP) — When the call went out for a doctor on board, the U.S. surgeon general says he gladly stepped in to help with a medical emergency on a commercial flight.
JACKSON, Miss. — When the call went out for a doctor on board, the U.S. surgeon general says he gladly stepped in to help with a medical emergency on a commercial flight.
Last week, Latin American carriers — GOL Linhas Aereas Inteligentes S.A. (GOL - Free Report) and Copa Holdings, S.A. (CPA - Free Report) — reported contrasting financial numbers for the first quarter of 2018. While Copa Holdings outperformed with respect to earnings per share and revenues driven by the improvement in the Latin American economy, GOL Linhas posted in-line earnings and lower-than-expected revenues.
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...
2018-05-19 - Asif
Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...
2018-05-17 - Asif
Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...
as of ET